CDC program reduces teen AIDS/STD risk

Article Abstract:

An AIDS program instituted by the Centers for Disease Control and Prevention is touted to promote safe sex among teenagers. An evaluation of the two-year 'Safer Choices' program at the 12th World AIDS Conference in Geneva, Switzerland, from Jun 28-Jul 3, 1998 showed that there were substantially fewer episodes of unprotected sex among the 2,000 ninth-grade students who participated, both in the short- and long-term. The use of HIV and pregnancy prevention methods was greater among the participating students, compared to the 2,000 who received the usual HIV/STD prevention curriculum.

Sexual behavior, Sexually transmitted diseases, Analysis, Prevention, Social policy, Teenagers, Sexually transmitted disease prevention, Safe sex, United States. Centers for Disease Control and Prevention, Teenage sexual behavior

---

U.S. market for AIDS therapies $1 billion and growing

Article Abstract:

AIDS therapies in the US posted a whopping 195.7% increase in 1997, rising to $1 billion during the year as against the previous year's level. A report by management consultancy firm Datamonitor predicts that the US market for AIDS therapies will continue to grow until the end of the 1990s. The US market greatly contributed to the growth of the world market for AIDS therapies, which expanded by 215% in 1996 and further by 105% in 1997.

Pharmaceutical industry, Statistics, Drug therapy

---

Similar abstracts:

• Abstracts: Scientific and ethical issues in AIDS vaccines. AIDS strengthens its grip on the world. AIDS affects us all
• Abstracts: The Clapham train collision. ... All this and then Paddington
• Abstracts: More precision in diagnosing appendicitis. Indications for computed tomography in patients with minor head injury
• Abstracts: CDC sharpens tools for vaccine-safety surveillance. 2002 vaccine market: $7 billion. Unprecedented protection with prime/boost malaria vaccine
• Abstracts: Desrosiers defends live AIDS vaccine, urges monkey trial. Tiered pricing: a solution to vaccine access?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.